Header Logo

Connection

Mazvita Muchengeti to HIV Infections

This is a "connection" page, showing publications Mazvita Muchengeti has written about HIV Infections.
Connection Strength

1,979
  1. Incidence and epidemiology of conjunctival squamous cell carcinoma in relation to the HIV epidemic in South Africa: a 25-year analysis of the National Cancer Registry (1994-2018). Br J Ophthalmol. 2024 01 29; 108(2):175-180.
    View in: PubMed
    Score: 0,256
  2. Decreasing incidence of conjunctival squamous cell carcinoma in people with HIV in South Africa. J Natl Cancer Inst. 2023 10 09; 115(10):1213-1219.
    View in: PubMed
    Score: 0,251
  3. Cohort profile: the South African HIV Cancer Match (SAM) Study, a national population-based cohort. BMJ Open. 2022 04 11; 12(4):e053460.
    View in: PubMed
    Score: 0,226
  4. Cancer in HIV-positive and HIV-negative adolescents and young adults in South Africa: a cross-sectional study. BMJ Open. 2021 10 18; 11(10):e043941.
    View in: PubMed
    Score: 0,219
  5. Conjunctival cancer in people living with HIV. Curr Opin Infect Dis. 2021 02 01; 34(1):1-7.
    View in: PubMed
    Score: 0,208
  6. Cancer in People with HIV. Infect Dis Clin North Am. 2024 Sep; 38(3):531-557.
    View in: PubMed
    Score: 0,067
  7. Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status. Int J Cancer. 2024 Jul 15; 155(2):251-260.
    View in: PubMed
    Score: 0,065
  8. State of the science and future directions for research on HIV and cancer: Summary of a joint workshop sponsored by IARC and NCI. Int J Cancer. 2024 Feb 15; 154(4):596-606.
    View in: PubMed
    Score: 0,062
  9. Gynaecologic and breast cancers in women living with HIV in South Africa: A record linkage study. Int J Cancer. 2024 Jan 15; 154(2):284-296.
    View in: PubMed
    Score: 0,062
  10. No woman left behind: achieving cervical cancer elimination among women living with HIV. Lancet HIV. 2023 06; 10(6):e412-e420.
    View in: PubMed
    Score: 0,061
  11. Age and Cancer Incidence in 5.2 Million People With Human Immunodeficiency Virus (HIV): The South African HIV Cancer Match Study. Clin Infect Dis. 2023 04 17; 76(8):1440-1448.
    View in: PubMed
    Score: 0,061
  12. Kaposi sarcoma-associated herpesvirus, HIV-1 and Kaposi sarcoma risk in black South Africans diagnosed with cancer during antiretroviral treatment rollout. Int J Cancer. 2023 05 15; 152(10):2081-2089.
    View in: PubMed
    Score: 0,060
  13. Prevalence of multimorbidity in men of African descent with and without prostate cancer in Soweto, South Africa. PLoS One. 2022; 17(10):e0276050.
    View in: PubMed
    Score: 0,059
  14. Epidemiology of Kaposi's sarcoma in sub-Saharan Africa. Cancer Epidemiol. 2022 Jun; 78:102167.
    View in: PubMed
    Score: 0,057
  15. Lifestyle factors associated with sex differences in Kaposi sarcoma incidence among adult black South Africans: A case-control study. Cancer Epidemiol. 2022 Jun; 78:102158.
    View in: PubMed
    Score: 0,057
  16. Cancer risk in adolescents and young adults living with HIV in South Africa: a nationwide cohort study. Lancet HIV. 2021 10; 8(10):e614-e622.
    View in: PubMed
    Score: 0,054
  17. Immunodeficiency and Cancer in 3.5 Million People Living With Human Immunodeficiency Virus (HIV): The South African HIV Cancer Match Study. Clin Infect Dis. 2021 08 02; 73(3):e735-e744.
    View in: PubMed
    Score: 0,054
  18. The impact of the South African antiretroviral treatment programme on the age-standardised incidence rate of Kaposi sarcoma, 1999-2016: An interrupted time series analysis. Int J Infect Dis. 2021 Jan; 102:20-27.
    View in: PubMed
    Score: 0,051
  19. Epidemiology of haematological malignancies in people living with HIV. Lancet HIV. 2020 09; 7(9):e641-e651.
    View in: PubMed
    Score: 0,050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.